Trupanion Inc header image

Trupanion Inc

TRUP

Equity

ISIN US8982021060 / Valor 24738737

NASDAQ (2024-09-18)
USD 45.81-1.59%

Trupanion Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Trupanion Inc is a pet insurance company that was founded in 2000 by Darryl Rawlings, with the aim of providing affordable life-saving coverage for cats and dogs. The company quickly expanded its operations from Canada to the U.S in 2008, and has since grown to insure over 500,000 pets in North America. Trupanion works in partnership with veterinarians to offer a product tailored to the needs of pet owners, with over $1 billion in paid claims on behalf of its members as of 2020.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Total Revenue

Trupanion Inc. reported total revenue of $306.1 million for the first quarter of 2024, marking a 19% increase compared to the first quarter of 2023. This growth reflects the company's continued expansion and strong market presence in the pet insurance industry.

Subscription Revenue

In the first quarter of 2024, Trupanion Inc.'s subscription business revenue reached $201.1 million, representing a 22% year-over-year increase. This significant growth underscores the company's success in attracting and retaining pet owners through its subscription model.

Net Loss

Trupanion Inc. reported a net loss of $(6.9) million, or $(0.16) per basic and diluted share, for the first quarter of 2024. This is a notable improvement compared to the net loss of $(24.8) million, or $(0.60) per basic and diluted share, in the first quarter of 2023.

Adjusted EBITDA

For the first quarter of 2024, Trupanion Inc. achieved an adjusted EBITDA of $4.8 million, a significant turnaround from the adjusted EBITDA of $(4.9) million reported in the same period of the previous year. This positive shift highlights the company's improved operational efficiency and financial health.

Operating and Free Cash Flow

Trupanion Inc. generated $2.4 million in operating cash flow and reported a free cash flow of $(0.6) million for the first quarter of 2024. This compares favorably to the operating cash flow of $(6.9) million and free cash flow of $(12.0) million in the first quarter of 2023, indicating better cash management and financial performance.

Summarized from source with an LLMView Source

Key figures

57.8%1Y
-44.6%3Y
69.1%5Y

Performance

84.6%1Y
83.5%3Y
76.0%5Y

Volatility

Market cap

1963 M

Market cap (USD)

Daily traded volume (Shares)

374,326

Daily traded volume (Shares)

1 day high/low

49.14 / 45.15

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.18%SEK 237.80
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.88%SEK 68.70
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%SEK 170.30
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%SEK 663.00
4basebio PLC
4basebio PLC 4basebio PLC Valor: 112829117
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 17.10
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.34%USD 49.78
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.13%USD 30.32
Oncopeptides AB
Oncopeptides AB Oncopeptides AB Valor: 35671972
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.46%SEK 2.09
dentalcorp Holdings Ltd
dentalcorp Holdings Ltd dentalcorp Holdings Ltd Valor: 111405816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.80%CAD 8.17
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%USD 580.65